StockNews.com Initiates Coverage on Brainstorm Cell Therapeutics (NASDAQ:BCLI)
Equities research analysts at StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Price Performance BCLI opened at $1.73 on Friday. The business has a 50 day simple moving […]
Equities research analysts at StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Price Performance BCLI opened at $1.73 on Friday. The business has a 50 day simple moving […]
